Clinical uses of insulin-like growth factor I.
Hussain
M A
MA
Department of Internal Medicine, University Hospital of Zurich, Switzerland.
Froesch
E R
ER
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D006130:Growth Disorders / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000502:physiology / Q000627:therapeutic use*; D010024:Osteoporosis / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology
D007334:Insulin-Like Growth Factor I